Cargando…
Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214199/ https://www.ncbi.nlm.nih.gov/pubmed/37186868 http://dx.doi.org/10.1073/pnas.2306087120 |
Ejemplares similares
-
Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target
por: Zhou, Junzhi, et al.
Publicado: (2023) -
Letter to the Editor in Response to Zhou et al
por: Troth, Sean, et al.
Publicado: (2021) -
Correction for Zhou et al., “Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections”
por: Zou, Jing, et al.
Publicado: (2022) -
Correction for Zhou et al., “Genome- and Community-Level Interaction Insights into Carbon Utilization and Element Cycling Functions of Hydrothermarchaeota in Hydrothermal Sediment”
por: Zhou, Zhichao, et al.
Publicado: (2022) -
Correction: Zhou, P., et al. Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy. Cells, 2019, 8, 213
por: Zhou, Ping, et al.
Publicado: (2020)